All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 66 of 206 pages ‹ First < 64 65 66 67 68 > Last ›
HSL12924
Bohrer RA.
Reach-through claims for drug target patents: Rx for pharmaceutical policy.
Nat Biotechnol 2008 Jan;26:(1):55-6
http://www.nature.com/nbt/journal/v26/n1/abs/nbt0108-55.html;jsessionid=0F293AA2AD8FD1645C3D814D3C88C130
HSL12925
Frew SE, Sammut SM, Shore AF, Ramjist JK, Al-Bader S, Rezaie R, Daar AS, Singer PA.
Chinese health biotech and the billion-patient market.
Nat Biotechnol 2008 Jan;26:(1):37-53
http://www.nature.com/nbt/journal/v26/n1/abs/nbt0108-37.html
HSL12926
.
The regulator disapproves.
Nat Biotechnol 2008 Jan;26:(1):1
http://www.nature.com/nbt/journal/v26/n1/abs/nbt0108-1.html
HSL12961
Al-Jazairi AS, Bhareth S, Eqtefan IS, Al-Suwayeh SA.
Brand and generic medications: Are they interchangeable?
Ann Saudi Med. 2008 Jan-Feb;28:(1):33-41
http://www.ncbi.nlm.nih.gov/pubmed/18299655
HSL12969
Moran N.
Fractured European market undermines biosimilar launches.
Nat Biotechnol. 2008 Jan;26:(1):5-6
http://www.nature.com/doifinder/10.1038/nbt0108-5
HSL13055
Puliyel JM, Madhavi Y.
Vaccines: Policy for public good or private profit?
Indian J Med Res 2008 Jan;127:(1):1-3
www.icmr.nic.in/ijmr/2008/january/editorial1.pdf
HSL13256
Schetky DH.
Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
Child Adolesc Psychiatr Clin N Am 2008 Jan;17:(1):113-25,
http://linkinghub.elsevier.com/retrieve/pii/S1056-4993(07)00075-2
HSL13381
Outterson K, Kesselheim AS.
Market-based licensing for HPV vaccines in developing countries.
Health Aff (Millwood) 2008 Jan-Feb;27:(1):130-9
http://content.healthaffairs.org/cgi/content/abstract/27/1/130
HSL13385
Goldman DP, Jena AB, Philipson T, Sun E.
Drug licenses: a new model for pharmaceutical pricing.
Health Aff (Millwood) 2008 Jan-Feb;27:(1):122-9
http://content.healthaffairs.org/cgi/content/abstract/27/1/122
HSL13443
Hartley H, Coleman CL.
News media coverage of direct-to-consumer pharmaceutical advertising: implications for countervailing powers theory.
Health (London) 2008 Jan;12:(1):107-32
http://hea.sagepub.com/cgi/content/abstract/12/1/107
HSL13499
Caulin C.
[History of the evaluation of medicines aiming for marketing authorization].
J Fr Ophtalmol. 2008 Jan;31:(1):71-4
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=370&CodeRevue4=JFO&Path=REVUE/JFO/2008/31/1/ARTICLE120281938714.xml&Locations=
HSL13785
Dens N, Eagle LC, De Pelsmacker P.
Attitudes and self-reported behavior of patients, doctors, and pharmacists in New Zealand and Belgium toward direct-to-consumer advertising of medication.
Health Commun 2008 Jan-Feb;23:(1):45-61
http://www.informaworld.com/smpp/content~db=all?content=10.1080/10410230701805190
HSL13802
Grosjean OV.
The resistible growth of health care costs.
Acta Chir Belg 2008 Jan-Feb;108:(1):4-14
http://www.ncbi.nlm.nih.gov/pubmed/18411565
HSL13947
Mohapatra PR.
Interaction between medical practitioners & pharmaceutical industry.
Indian J Med Res. 2008 Jan;127:(1):93
http://www.icmr.nic.in/ijmr/2008/january/0115.pdf
HSL13973
Boyd MA, Roth K, Ralls SA, Chambers DW.
Beginning the discussion of commercialism in dentistry.
J Calif Dent Assoc 2008 Jan;36:(1):57-65
http://www.cda.org/page/Library/cda_member/pubs/journal/jour0108/boyd.pdf
HSL14649
The indifferent industry: Big Pharma, essential medicines and Africa’s sick
: Forum for African Investigative Reporters (FAIR) 2008 Jan
http://www.mo.be/en/article/indifferent-industry
HSL15229
Islam MS, Farah SS.
Characteristics and Reliability of Online References Cited in the Pharmaceutical Promotional Brochures of Bangladesh
eHealth International Journal 2008 Jan;4:(1):1-5
http://www.ehealthinternational.org/vol4num1/Vol4Num1p01.pdf
HSL15260
Islam MS, Farah SS.
Drug promotional brochure as a source of drug information in Bangladesh: a critical analysis of the brochures for the authenticity of information.
Calicut Medical Journal 2008 Jan-Mar;6:(1):e5
http://calicutmedicaljournal.info/2008/1/e5.pdf
HSL15261
Thomas V.
Drugs: prescription and promotion in third world countries
Calicut Medical Journal 2008 Jan-Mar;6:(1):e1
http://calicutmedicaljournal.info/2008/1/e1.pdf
HSL16505
Huff-Rousselle M
Global pharmaceuticals: ethics, markets, practices [Book review]
The International Journal of Health Planning and Management 2008 Jan;23:(1):79-82
http://www3.interscience.wiley.com/journal/117925549/abstract
HSL19337
Stossel TP.
Response to AMA's Council on Ethical and Judicial Affairs draft report on 'Ethical guidance for physicians and the profession with respect to industry support for professional education in medicine'
Medscape J Med 2008 12;10:(6):137
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491684/?tool=pubmed
HSL19338
Stossel TP.
A biopsy of financial conflicts of interest in medicine.
Surgery 2008;143:(2):193-8
http://www.surgjournal.com/article/S0039-6060(07)00747-7/abstract
HSL19028
Herndon MB, Schwartz LM, Woloshin S, Anthony D, Gallagher P, Fowler FJ, Fisher E.
Older patients perceptions of 'unnecessary' tests and referrals: a national survey of Medicare beneficiaries.
J Gen Intern Med 2008;23:(10):1547-54
http://www.springerlink.com/content/935q6u7727u36226/
HSL12276
Henderson J, Miller G, Pan Y, Britt H.
The effect of advertising in clinical software on general practitioners’ prescribing behaviour
The Medical Journal of Australia 2008;188:(1):15-20
http://www.mja.com.au/public/issues/188_01_070108/hen10412_fm.html
HSL12277
Harvey K, Korczak VS, Marron LJ, Newgreen DB.
Commercialism, choice and consumer protection: regulation of complementary medicines in Australia
The Medical Journal of Australia 2008;188:(1):21-25
http://www.mja.com.au/public/issues/188_01_070108/har10522_fm.html
HSL12278
Raftery JP.
Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand
The Medical Journal of Australia 2008;188:(1):26-28
http://www.mja.com.au/public/issues/188_01_070108/raf10125_fm.html
HSL12319
Dach C.
The Media's New Aesthetic: Why TV is About to Have a Major Mood Swing.
Adbusters 2008
http://www.adbusters.org
HSL12375
Lin HY, Liao CC, Cheng SH, Wang PC, Hsueh YS.
Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases: experience in a taiwanese medical setting.
Drugs Aging 2008;25:(1):49-59
http://www.ncbi.nlm.nih.gov/pubmed/18184029?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL12444
Adler NE, Koschorreck J, Rechenberg B.
Environmental impact assessment and control of pharmaceuticals: the role of environmental agencies.
Water Sci Technol 2008;57:(1):91-7
http://www.ncbi.nlm.nih.gov/pubmed/18192745
HSL12446
Montagne M.
Drugs on the internet. I: introduction and web sites on psychedelic drugs.
Subst Use Misuse. 2008;43:(1):17-25
http://www.informaworld.com/smpp/content?content=10.1080/10826080701690698
HSL12447
Woodcock J, Woosley R.
The FDA critical path initiative and its influence on new drug development.
Annu Rev Med 2008;59:1-12:
http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.med.59.090506.155819
HSL12511
Coombes ID, Stowasser DA, Coombes JA, Mitchell C.
Why do interns make prescribing errors? A qualitative study
MJA 2008;18:(2):89-94
http://www.mja.com.au/public/issues/188_02_210108/coo10971_fm.html
HSL12512
Millar JA, Silla RC, Lee GE, Berwick A.
The national inpatient medication chart: critical audit of design and performance at a tertiary hospital
MJA 2008;188:(2):95-99
http://www.mja.com.au/public/issues/188_02_210108/mil10878_fm.html
HSL12513
Hassali MAA, Stewart K, Kong DCM.
A national survey on knowledge and perceptions of senior medical students in Australia about generic medicines
MJA 2008;188:(2):123-4
http://www.mja.com.au/public/issues/188_02_210108/letters_210108_fm-4.html
HSL12534
Loewenberg S.
Drug company trials come under increasing scrutiny
The Lancet 2008;371:(9608):191-2
http://www.thelancet.com/journals/lancet/article/PIIS0140673608601191/fulltext
HSL12704
Etwel FA, Rieder MJ, Bend JR, Koren G.
A Surveillance Method for the Early Identification of Idiosyncratic Adverse Drug Reactions.
Drug Saf 2008;31:(2):169-180
http://www.ncbi.nlm.nih.gov/pubmed/18217792
HSL12705
Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AC.
Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users : A Cohort Study Using Pharmacy Dispensing Data in The Netherlands.
Drug Saf 2008;31:(2):143-58
http://www.ncbi.nlm.nih.gov/pubmed/18217790
HSL12721
Morgan S, Cunningham C.
The Effect of Evidence-Based Drug Coverage Policies on Pharmaceutical R&D: A Case Study from British Columbia
Longwoods Publishing 2008;
http://www.longwoods.com/product.php?productid=19524&page=1
HSL12762
Donner-banzhoff N, Sönnichsen A.
Strategies for prescribing statins
BMJ 2008;336:(7639):288
http://www.bmj.com/cgi/content/extract/336/7639/288?etoc
HSL12918
Kapsak WR, Schmidt D, Childs NM, Meunier J, White C.
Consumer perceptions of graded, graphic and text label presentations for qualified health claims.
Crit Rev Food Sci Nutr 2008;48:(3):248-56
http://www.informaworld.com/smpp/content?content=10.1080/10408390701286058
HSL12940
Matthews RA.
Medical progress depends on animal models - doesn't it?
J R Soc Med 2008;101:(2):95-98
http://www.jrsm.org/cgi/content/full/101/2/95
HSL13177
Morgan S, Lopert R, Greyson D.
Toward a definition of pharmaceutical innovation
Open Medicine 2008;2:(1):epub
http://www.openmedicine.ca/article/view/153/106
HSL13203
Petersen M.
Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs
New York: Sarah Crichton Books/Farrar, Straus and Giroux 2008
http://www.fsgbooks.com/fsg/08_dailymeds.html
HSL13213
Griffiths S.
Pharmaceutical branding: 'To brand or not to brand'
Journal of Medical Marketing 2008;8:(2):113–118
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050125a.html
HSL13214
Raasch C.
Launching a fighter brand to cushion patent expiry: The case of Zocor
Journal of Medical Marketing 2008;8:(2):119–126
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050140a.html
HSL13215
Ware C, Buckwell C, Small S, Wood R.
Activation of evidence: A new approach to knowledge translation and closing the clinical care gap
Journal of Medical Marketing 2008;8:(2):127–136
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050142a.html
HSL13216
Heiens RA, McGrath LC, Leach RT.
The impact of intangible assets and expenditures on holding period returns in the pharmaceutical industry
Journal of Medical Marketing 2008;8:(2):151–158
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050131a.html
HSL13217
Naboko D, Petkova V, Dimitrova Z.
Combination of marketing strategies for increase of anti-smoking drugs sales
Journal of Medical Marketing 2008;8:(2):144–150
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050097a.html
HSL13218
Ham CD, Jun JW, Lee H-S.
How to reach consumers in a market where DTC is not allowed
Journal of Medical Marketing 2008;8:(2):159–168
http://www.palgrave-journals.com/jmm/journal/v8/n2/abs/5050123a.html
HSL13424
Kruszewski SP, Paczynski RP, Marzana BIALY.
State Medical Board Responses To An Inquiry On Physician Researcher Misconduct
Journal of Medical Licensure and Discipline 2008;94:(1):
http://web.archive.org/web/20090915182840/http://www.journalonline.org/index.cfm
HSL13613
Alkhateeb , Fma .
Influences on physicians' adoption of e-detailing
2008
HSL13630
Huddle TS.
Drug Reps and the Academic Medical Center: a case for management rather than prohibition.
Perspect Biol Med 2008 Spr;51:(2):251-60
http://muse.jhu.edu/login?uri=/journals/perspectives_in_biology_and_medicine/v051/51.2.huddle.htmlhttp://
HSL13634
Bush A.
Regulating spoons
Eur Respir J 2008;31:(4):699-700
http://erj.ersjournals.com/cgi/content/full/31/4/699
HSL13666
Ta S, Frosch DL.
Pharmaceutical Product Placement: Simply Script or Prescription for Trouble?
Journal of Public Policy & Marketing 2008 Spring;27:(1):98–106
http://www.marketingpower.com/content17870.php
HSL13683
Weinbach D.
10 steps to reaching physicians.
Mark Health Serv 2008 Spr;28:(1):41-2
http://www.ncbi.nlm.nih.gov/pubmed/18389856
HSL13686
Lexchin J.
Drug Approval Times and User Fees: An International Perspective in a Changing World
Pharm Med 2008;22:(1):1-11
http://www.ingentaconnect.com/content/adis/ipm
HSL13687
Cassels A, Lexchin J.
How well do Canadian media outlets convey medical treatment information?
Open Medicine 2008;2:(2):epub
http://www.openmedicine.ca/article/view/170/131
HSL13695
Kurzlechner W.
Ärzte fassen sich an die eigene Nase
Pharmazeutische Zeitung 2008
http://www.pharmazeutische-zeitung.de/index.php?id=5727&type=0
HSL13835
Huskamp HA, Donohue JM, Koss C, Berndt ER, Frank RG.
Generic Entry, Reformulations and Promotion of SSRIs in the US.
Pharmacoeconomics 2008;26:(7):603-16
http://www.ncbi.nlm.nih.gov/pubmed/18563951
HSL13836
Schwartz MI.
To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
Food Drug Law J 2008;63:(1):1-33
http://www.ncbi.nlm.nih.gov/pubmed/18561453
HSL13864
Charter challenge on drugs ads: A challenge in the wrong direction
The Canadian Women's Health Network Magazine 2008
http://www.cwhn.ca/network-reseau/10-2/10-2pg5.html
HSL13865
Lippman A, Rochon Ford A, O’Grady K.
Barbara Seaman (1935-2008): Pioneer in the women’s health movement
The Canadian Women's Health Network Magazine 2008
http://www.cwhn.ca/network-reseau/10-2/10-2pg8.html
HSL13894
Taylor E.
Illegal human growth hormone markets. Issues in controlling online drug sales and advertising
Journal of Legal Medicine 2008;
http://www.informaworld.com/smpp/content~db=all?content=10.1080/01947640802080504
HSL14011
Montoya ID, Lee-Dukes G, Shah D.
Direct-to-consumer advertising: its effects on stakeholders.
J Allied Health 2008 Sum;37:(2):116-20
http://www.ingentaconnect.com/content/asahp/jah/2008/00000037/00000002/art00010?token=005c1e1cc1da5930b292c37e41225f406a432c40632148763c24442a576b3427656c3c6a333f25661453d5587f30
HSL14065
Ecks S.
Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis' anti-cancer drug Glivec
Biosocieties 2008;(3):165-181
http://www.health.ed.ac.uk/CIPHP/ourresearch/documents/Glivec_Ecks_2008_for_TPSA_website.pdf
HSL14080
Giampaolo V, Riccardo R, Roberto S.
Drugs in the newspapers.
Drugs 2008;68:(7):1017-8
http://drugs.adisonline.com/pt/re/drugs/toc.00003495-200868070-00000.htm
HSL14091
Nguyen ES.
Weight loss testimonials: a critique of potential FTC restrictions on diet advertising.
Food Drug Law J. 2008;63:(2):493-507
http://www.ncbi.nlm.nih.gov/pubmed/18561474
HSL14223
Carrigan N, Raynor DK, Knapp P.
Adequacy of patient information on adverse effects: an assessment of patient information leaflets in the UK.
Drug Saf 2008;31:(4):305-12
http://www.ncbi.nlm.nih.gov/pubmed/18366241
HSL14238
Haines IE, Olver IN.
Are self-regulation and declaration of conflict of interest still the benchmark for relationships between physicians and industry?
eMJA 2008;189:(5):263-266
http://www.mja.com.au/public/issues/189_05_010908/hai10221_fm.html
HSL14244
Joseph M, Spake DF, Finney Z.
Consumer attitudes toward pharmaceutical direct-to-consumer advertising: An empirical study and the role of income
International Journal of Pharmaceutical and Healthcare Marketing 2008;2:(2):117 - 133
http://www.emeraldinsight.com/10.1108/17506120810887916
HSL14289
Demaria AN.
Continuing education, industry, and physicians
J Am Coll 2008;52:1035-1036.
HSL14334
Healy D.
Our Censored Journals
Mens Sana Monographs 2008;6:(1):244-256
http://www.msmonographs.org/article.asp?issn=0973-1229;year=2008;volume=6;issue=1;spage=244;epage=256;aulast=Healy
HSL14336
Civaner M.
[A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
Turk Psikiyatri Derg. 2008;19:(3):310-7
http://www.turkpsikiyatri.com/ftr.aspx?id=641
HSL14349
Jureidini J, Mintzes B, Raven M.
Does direct-to-consumer advertising of antidepressants lead to a net social benefit?
Pharmacoeconomics 2008;26:(7):557-66;
http://www.ncbi.nlm.nih.gov/pubmed/18563947
HSL14367
Morrow LE, Kollef MH.
Probiotics in the intensive care unit: why controversies and confusion abound.
Crit Care. 2008;12:(3):160
http://ccforum.com/content/12/3/160
HSL14402
Lee PE, Fischer HD, Rochon PA, Gill SS, Herrmann N, Bell CM.
Published randomized controlled trials of drug therapy for dementia
Journal of Clinical Epidemiology 2008;61:1152-1160
HSL14423
Rutter P, Gilbody S.
The European pharmaceutical industry: coming to a screen near you?
J R Soc Med 2008;101:(10):485–488.
http://jrsm.rsmjournals.com/cgi/content/full/101/10/485
HSL14445
Pollock A.
Pharmaceutical meaning-making beyond marketing: racialized subjects of generic thiazide.
J Law Med Ethics. 2008 Fal;36:(3):530-6
http://www3.interscience.wiley.com/journal/121385670/abstract?CRETRY=1&SRETRY=0
HSL14446
Hudec R, Kriska M, Bozekova L, Foltan V.
Comparison of NSAID consumption in Slovakia, Finland and Norway.
Bratisl Lek Listy. 2008;109:(8):370-3
http://www.ncbi.nlm.nih.gov/pubmed/18837248?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
HSL14550
Lemmens T, Luther L.
Financial conflict of interest in medical research
Singer PA, Viens AM. The Cambridge Textbook of Bioethics New York: Cambridge University Press 2008
http://www.cambridge.org/catalogue/catalogue.asp?isbn=9780521694438
HSL14600
Brezis M.
Big pharma and health care: unsolvable conflict of interests between private enterprise and public health.
Isr J Psychiatry Relat Sc 2008;45:(2):83-9;
http://www.ncbi.nlm.nih.gov/pubmed/18982834
HSL14613
Ramsey S, Scoggins J.
Commentary: Practicing on the Tip of an Information Iceberg Evidence of Underpublication of Registered Clinical Trials in Oncology
The Oncologist 2008;13:925–929
http://www.theoncologist.com/cgi/reprint/theoncologist.2008-0133v1.pdf
HSL14639
Glaeske G.
[Why are some drugs so expensive? The price policy of pharmaceutical companies--'digging the grave of our health insurance-system'?]
Z Evid Fortbild Qual Gesundhwes 2008;102:(4):269-77
http://www.ncbi.nlm.nih.gov/pubmed/19004366
HSL14695
Parrott R, Volkman J, Ghetian C, Weiner J, Raup-Krieger J, Parrott J.
Memorable messages about genes and health: implications for direct-to-consumer marketing of genetic tests and therapies.
Health Mark Q. 2008;25:(1-2):8-32
http://www.ncbi.nlm.nih.gov/pubmed/18935878
HSL14698
14 Drugs Identified as Most Urgently Needing Study for Off-Label Use, Stanford Professor Says
Fierce Biotech 2008
http://med.stanford.edu/news_releases/2008/november/off-label.html
HSL14724
Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart A, Choudhry NK, Shrank WH.
Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease: A Systematic Review and Meta-analysis
JAMA 2008;300:(21):2514-2526.
http://www.ionchannels.org/showabstract.php?metaid=154075&redirect=yes&terms=Clinical+Equivalence+of+Generic+and+Brand-Name+Drugs+Used+in+Cardiovascular+Disease:+A+Systematic+Review+and+Meta-analysis
HSL14843
Shani S, Yahalom Z.
The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
Food Drug Law J. 2008;63:(3):701-11
http://www.ncbi.nlm.nih.gov/pubmed/19031669
HSL14850
Segman R, Weizman A
Drug industry, psychopharmacology, and mental health care needs: where do we go from here?
Isr J Psychiatry Relat Sci. 2008;45:(2):71-9
http://www.ncbi.nlm.nih.gov/pubmed/18982832?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
HSL14852
Jacobstein JM.
Federal regulatory pre-emption of state tort claims against the manufacturers of medical devices and pharmaceutical drugs.
J Law Med Ethics. 2008 Fal;36:(3):594-7
http://www3.interscience.wiley.com/journal/121385673/abstract?CRETRY=1&SRETRY=0
HSL14855
Hogarth S, Javitt G, Melzer D.
The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues.
Annu Rev Genomics Hum Genet 2008;9:161-82
http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.genom.9.081307.164319?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov
HSL14878
Fugh-Berman A, Dodgson SJ.
Ethical considerations of publication planning in the pharmaceutical industry
Open Medicine 2008;2:(4):
http://www.openmedicine.ca/article/view/118/215
HSL14894
Ulaş H, Bınbay T, Alptekın K.
[Financial Conflict of Interest in Clinical Psychiatry Studies: A Review].
Turk Psikiyatri Derg. 2008 Win;19:(4):418-426
http://www.turkpsikiyatri.com/ftr.aspx?id=670
HSL14899
Lexchin J
Clinical trials in Canada: whose interests are paramount?
Int J Health Serv 2008;38:(3):525-42
http://www.ncbi.nlm.nih.gov/pubmed/18724580
HSL15071
Health Action International- Asia Pacific
Multi country Survey on Banned and Restricted Pharmaceuticals
Colombo, Sri Lanka: Health Action International- Asia Pacific 2008 August
http://haiap.org/upload/project-banned.pdf
HSL15074
International Comparative Legal Guide Series: Pharmaceutical Advertising 2008
: Global Legal Group Limited 2008
http://www.iclg.co.uk/index.php?area=4&kh_publications_id=81
HSL15095
Matheson A.
Corporate Science and the Husbandry of Scientific and Medical Knowledge by the Pharmaceutical Industry
BioSocieties 2008;3:355–382
http://www.admatheson.com/AM%20BioSocieties%20paper%20Dec%2008.pdf
HSL15183
Norey E, Simone TM, Mousa SA.
The Impact of Direct-to-Consumer Advertised Drugs on Drug Sales in the US and New Zealand.
Appl Health Econ Health Policy. 2008;6:(2-3):93-102
http://www.ncbi.nlm.nih.gov/pubmed/19231903
HSL15850
National Task Force on CME Provider/Industry Collaboration
Continuing Medical Education: Addressing Conflict of Interest (COI)
: National Task Force on CME Provider/Industry Collaboration 20081:(2):
http://www.aafp.org/online/etc/medialib/aafp_org/documents/cme/cmea/ntf-facts2.Par.0001.File.dat/cmea_NTF_facts2.pdf
HSL16006
Campos Alves SM.
Processo de participação da sociedade civil nas consultas públicas realizadas pela Agência Nacional de Vigilância Sanitária - Anvisa
Departmento de Servico Social BrasÃlia: Universidade de Brasilia 2008
http://bdtd.bce.unb.br/tedesimplificado/tde_busca/arquivo.php?codArquivo=3663
HSL16344
Healy D
Mania: A Short History of Bipolar Disorder. Baltimore: Johns Hopkins University Press 2008
http://www.amazon.com/Mania-History-Bipolar-Disorder-Biographies/dp/0801888220
Page 66 of 206 pages ‹ First < 64 65 66 67 68 > Last ›
